Swiss stocks outperform European markets as investors retreat from AI trades
NVS Novartis AG ADR
$151.12 -3.30%
View chart & analysis → - 1The Swiss Market Index (SMI) rose 4.6% this month, contrasting with a 3.2% decline in the Euro Stoxx 50.
- 2Three companies, including Roche with a 12% rise and Novartis with a 6.7% rise in October, drove all the index gains.
- 3Damian Burkhardt, head of Swiss equities at EFG Asset Management, said investors are seeking alternatives to overheated AI positions.
So what's the key point?
Swiss stocks rose as people looked for alternatives to artificial intelligence-related stocks. Companies like Roche led the market, helping Swiss stocks perform better than those in Europe.
Source Investing.com · View original ↗
Nothing hidden: past picks and how they did against the S&P 500.